+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhaled Nitric Oxide Delivery Device Market - Global Forecast 2026-2032- Product Image
Inhaled Nitric Oxide Delivery Device Market - Global Forecast 2026-2032- Product Image
Sale

Inhaled Nitric Oxide Delivery Device Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6152419
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Inhaled Nitric Oxide Delivery Device Market is projected to reach USD 281.53 Million in 2026. It is expected to continue growing at a CAGR of 6.04%, reaching USD 398.22 Million by 2032.

Inhaled Nitric Oxide Delivery Devices: Executive Overview

Inhaled nitric oxide delivery devices support controlled administration of nitric oxide in clinical settings, particularly where selective pulmonary vasodilation and oxygenation management are required. Their use is closely linked to neonatal, pediatric, cardiac, pulmonary, and critical-care pathways. Device value depends on accurate dosing, reliable gas blending, continuous monitoring, alarm performance, and safe integration with ventilators and other respiratory equipment.

Clinical Integration and Safety Are Reshaping Device Requirements

The landscape is shifting from standalone gas-delivery equipment toward integrated systems that combine precision dosing, respiratory-circuit compatibility, monitoring, documentation, and workflow support. Hospitals increasingly prioritize uninterrupted operation, straightforward setup, maintenance efficiency, and safeguards against excessive exposure or inadequate delivery. Regulatory scrutiny, infection-prevention expectations, clinician training, and the need for reliable performance during patient transfers are also influencing procurement and implementation decisions.

Artificial Intelligence Strengthens Monitoring, Workflow, and Predictive Support

Artificial intelligence can improve inhaled nitric oxide delivery by identifying deviations in dose, flow, concentration, or circuit behavior and by supporting early detection of maintenance needs. Machine-learning tools may also help correlate device readings with respiratory and hemodynamic data, reducing manual review and strengthening documentation. These applications require validated algorithms, transparent alerts, cybersecurity controls, high-quality training data, and clear clinical accountability; AI should complement rather than replace clinician judgment.

Regional Priorities Differ Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America generally emphasizes advanced monitoring, interoperability, regulatory compliance, and hospital-standardization programs. Europe places strong importance on safety, device conformity, sustainability, and integration with coordinated health systems. Asia-Pacific combines rapidly developing tertiary-care capacity with substantial variation in neonatal and critical-care infrastructure, creating demand for adaptable systems and training support. Latin America often prioritizes affordability, service availability, and dependable supply across uneven hospital networks. Middle Eastern providers commonly focus on specialized-care capacity, centralized procurement, and workforce capability, while African markets place particular emphasis on ruggedness, technical support, oxygen-system compatibility, and solutions suited to resource-variable environments.

ASEAN, BRICS, European Union, G7, GCC, and NATO Show Distinct Adoption Contexts

ASEAN markets differ significantly in hospital capability, regulatory maturity, and access to respiratory specialists, making modular deployment and local training important. BRICS members reflect a mix of large tertiary-care systems, domestic manufacturing ambitions, and uneven access between metropolitan and regional facilities. European Union adoption is shaped by shared regulatory principles alongside national purchasing and reimbursement structures. G7 systems tend to emphasize evidence, interoperability, cybersecurity, and lifecycle support. GCC providers often invest in advanced hospital infrastructure and centralized clinical services, while NATO countries may place additional weight on supply resilience, standardization, transportability, and continuity of critical-care operations.

Country-Level Priorities Span Clinical Sophistication, Access, and Resilience

Australia and Canada emphasize geographically resilient service models and integration across specialized hospitals. Brazil, Mexico, India, and Russia face varied regional access and may prioritize cost control, local support, and dependable consumables. China and South Korea combine expanding advanced-care capabilities with interest in domestic technology ecosystems and digital integration. Japan emphasizes precision, reliability, and aging-care needs. France, Germany, Italy, and Spain operate within structured European regulatory and hospital environments while balancing procurement efficiency and clinical evidence. The United Kingdom focuses on centralized health-service requirements, interoperability, and operational value. The United States places strong emphasis on clinical protocols, device performance, compliance, and integration across complex critical-care workflows.

Industry Leaders Should Prioritize Safety, Interoperability, and Lifecycle Execution

Leaders should design devices around accurate delivery, robust alarms, simple clinician workflows, and compatibility with ventilators and monitoring platforms. They should validate performance across neonatal, pediatric, adult, transport, and resource-variable use cases rather than optimizing for a single care environment. Investment in cybersecurity, remote diagnostics, preventive maintenance, consumable continuity, and competency-based training can reduce operational risk. Regional strategies should reflect local infrastructure and service capacity, while evidence generation should document patient-safety outcomes, workflow effects, and total lifecycle performance without overstating clinical benefit.

Methodology: Structured Review of Clinical, Technical, Regulatory, and Regional Evidence

This executive summary is based on a structured interpretation of the defined inhaled nitric oxide delivery device category and the required geographic groupings. The assessment organizes publicly verifiable considerations across clinical applications, device functionality, safety controls, digital integration, infrastructure, procurement, and regulatory context. Regional, group, and country observations are presented as qualitative comparisons; no market estimates, forecasts, shares, or sizing assumptions are used. Conclusions should be validated against current clinical guidance, applicable regulations, hospital protocols, and product-specific technical documentation.

Reliable Delivery and Context-Aware Implementation Will Define Progress

Inhaled nitric oxide delivery devices are becoming more closely connected to critical-care workflows, respiratory monitoring, data systems, and hospital safety programs. The strongest implementation outcomes will depend on dependable dosing, transparent monitoring, trained users, resilient support, and evidence-based integration into clinical protocols. Manufacturers, providers, and policymakers should align technology development with patient safety, equitable access, interoperability, and long-term operational sustainability.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Inhaled Nitric Oxide Delivery Device Market, by Product Type
7.1. Introduction
7.2. Continuous Flow Devices
7.2.1. Portable Devices
7.2.2. Tabletop Devices
7.3. Pulsed Delivery Devices
8. Inhaled Nitric Oxide Delivery Device Market, by Mode Of Purchase
8.1. Introduction
8.2. Purchase
8.3. Rental
8.4. Service Agreements
9. Inhaled Nitric Oxide Delivery Device Market, by Age Group
9.1. Introduction
9.2. Adult
9.3. Neonatal
9.4. Pediatric
10. Inhaled Nitric Oxide Delivery Device Market, by Application
10.1. Introduction
10.2. Pulmonary Hypertension
10.2.1. Primary Pulmonary Hypertension
10.2.2. Secondary Pulmonary Hypertension
10.3. Respiratory Distress Syndrome
10.3.1. Adult Distress Syndrome
10.3.2. Neonatal Distress Syndrome
11. Inhaled Nitric Oxide Delivery Device Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Homecare Settings
11.4. Hospitals
11.4.1. Government Hospitals
11.4.2. Private Hospitals
12. Inhaled Nitric Oxide Delivery Device Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Inhaled Nitric Oxide Delivery Device Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Inhaled Nitric Oxide Delivery Device Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Air Liquide S.A.
16.2. Air Products and Chemicals, Inc.
16.3. Bellerophon Therapeutics, Inc.
16.4. Beyond Air, Inc.
16.5. Chiesi Farmaceutici S.p.A.
16.6. Circassia Pharmaceuticals plc
16.7. Draegerwerk AG & Co. KGaA
16.8. EKU Elektronik
16.9. General Electric Company
16.10. Getinge AB
16.11. International Biomedical
16.12. Koninklijke Philips N.V.
16.13. Linde plc
16.14. Mallinckrodt Pharmaceuticals Ireland UC
16.15. Merck KGaA
16.16. Ninox Medical Ltd.
16.17. NU-MED Plus
16.18. Praxair
16.19. SLE Ltd.
16.20. SOL SpA
16.21. Vero Biotech GmbH
16.22. VNG Medical Innovation System Pvt Ltd
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Inhaled Nitric Oxide Delivery Device Market, Years Considered for the Study
FIGURE 2. Global Inhaled Nitric Oxide Delivery Device Market, Research Design
FIGURE 3. Global Inhaled Nitric Oxide Delivery Device Market, Research Framework
FIGURE 4. Global Inhaled Nitric Oxide Delivery Device Market, Data Triangulation
FIGURE 5. Global Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2025 vs 2032 (%)
FIGURE 9. Global Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Inhaled Nitric Oxide Delivery Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Inhaled Nitric Oxide Delivery Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Inhaled Nitric Oxide Delivery Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Inhaled Nitric Oxide Delivery Device Market Segmentation & Coverage
TABLE 2. Global Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Continuous Flow Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Continuous Flow Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Continuous Flow Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Portable Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Portable Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Portable Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Tabletop Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Tabletop Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Tabletop Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pulsed Delivery Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pulsed Delivery Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pulsed Delivery Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 17. Global Purchase Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Purchase Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Purchase Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Rental Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Rental Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Rental Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Service Agreements Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Service Agreements Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Service Agreements Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 27. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Neonatal Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Neonatal Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Neonatal Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 37. Global Pulmonary Hypertension Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Pulmonary Hypertension Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Pulmonary Hypertension Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Primary Pulmonary Hypertension Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Primary Pulmonary Hypertension Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Primary Pulmonary Hypertension Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Secondary Pulmonary Hypertension Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Secondary Pulmonary Hypertension Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Secondary Pulmonary Hypertension Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Respiratory Distress Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Respiratory Distress Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Respiratory Distress Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Adult Distress Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Adult Distress Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Adult Distress Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Neonatal Distress Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Neonatal Distress Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Neonatal Distress Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 56. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Government Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Government Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Government Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 82. North America Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. North America Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. North America Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 85. North America Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 86. North America Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 87. North America Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. North America Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 89. North America Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 90. North America Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. North America Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 92. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 95. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 96. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 97. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 99. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 100. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Latin America Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 102. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 105. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 106. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 107. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 109. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 110. Europe Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Europe Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 112. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 115. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 116. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 117. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 119. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 120. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Middle East Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 122. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 125. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 126. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 127. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 129. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 130. Africa Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Africa Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 132. Global Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 136. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 137. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 138. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 140. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 141. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. ASEAN Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 143. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 146. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 147. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 148. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 150. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 151. GCC Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. GCC Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 153. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 156. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 157. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 158. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 160. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 161. European Union Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. European Union Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 163. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 166. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 167. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 168. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 170. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 171. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. BRICS Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 173. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 176. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 177. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 178. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 180. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 181. G7 Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. G7 Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 183. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 186. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 187. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 188. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 190. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 191. NATO Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. NATO Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 193. Global Inhaled Nitric Oxide Delivery Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 194. United States Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 195. United States Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. United States Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 197. United States Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 198. United States Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 199. United States Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. United States Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 201. United States Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 202. United States Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. United States Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 204. Canada Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 205. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 207. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 208. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 209. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 211. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 212. Canada Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Canada Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 214. Mexico Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 215. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 217. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 218. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 219. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 221. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 222. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Mexico Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 224. Brazil Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 225. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 227. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 228. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 229. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 231. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 232. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Brazil Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 234. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 235. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 236. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 237. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 238. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 239. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 241. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 242. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. United Kingdom Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 244. Germany Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 245. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 247. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 248. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 249. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 251. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 252. Germany Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Germany Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 254. France Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 255. France Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. France Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 257. France Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 258. France Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 259. France Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. France Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 261. France Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 262. France Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. France Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 264. Russia Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 265. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 267. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 268. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 269. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 271. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 272. Russia Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Russia Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 274. Italy Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 275. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 276. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 277. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 278. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 279. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 281. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 282. Italy Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 283. Italy Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 284. Spain Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 285. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 286. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 287. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 288. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 289. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 291. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 292. Spain Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. Spain Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 294. China Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 295. China Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. China Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 297. China Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 298. China Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 299. China Inhaled Nitric Oxide Delivery Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. China Inhaled Nitric Oxide Delivery Device Market Size, by Pulmonary Hypertension, 2017-2032 (USD Million)
TABLE 301. China Inhaled Nitric Oxide Delivery Device Market Size, by Respiratory Distress Syndrome, 2017-2032 (USD Million)
TABLE 302. China Inhaled Nitric Oxide Delivery Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. China Inhaled Nitric Oxide Delivery Device Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 304. India Inhaled Nitric Oxide Delivery Device Market Size, 2017-2032 (USD Million)
TABLE 305. India Inhaled Nitric Oxide Delivery Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 306. India Inhaled Nitric Oxide Delivery Device Market Size, by Continuous Flow Devices, 2017-2032 (USD Million)
TABLE 307. India Inhaled Nitric Oxide Delivery Device Market Size, by Mode Of Purchase, 2017-2032 (USD Million)
TABLE 308. India Inhaled Nitric Oxide Delivery Device Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 309. India Inhaled Nitric Oxide Delivery Device Market Size, by Application

Companies Mentioned

  • Air Liquide S.A.
  • Air Products and Chemicals, Inc.
  • Bellerophon Therapeutics, Inc.
  • Beyond Air, Inc.
  • Chiesi Farmaceutici S.p.A.
  • Circassia Pharmaceuticals plc
  • Draegerwerk AG & Co. KGaA
  • EKU Elektronik
  • General Electric Company
  • Getinge AB
  • International Biomedical
  • Koninklijke Philips N.V.
  • Linde plc
  • Mallinckrodt Pharmaceuticals Ireland UC
  • Merck KGaA
  • Ninox Medical Ltd.
  • NU‑MED Plus
  • Praxair
  • SLE Ltd.
  • SOL SpA
  • Vero Biotech GmbH
  • VNG Medical Innovation System Pvt Ltd

Related Topics

Related Reports

Inhaled Nitric Oxide Market Size, Share, Trends and Forecast by Application and Region, 2026-2034 - Product Image

Inhaled Nitric Oxide Market Size, Share, Trends and Forecast by Application and Region, 2026-2034

  • Report
  • 135 Pages
  • Global
From
Inhaled Nitric Oxide Delivery Systems Market - Global Forecast 2026-2032 - Product Image

Inhaled Nitric Oxide Delivery Systems Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Inhaled Nitric Oxide Market - Global Forecast 2026-2032 - Product Image

Inhaled Nitric Oxide Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Inhaled Nitric Oxide Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Inhaled Nitric Oxide Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 196 Pages
  • Global
From
Inhaled Nitric Oxide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Inhaled Nitric Oxide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.